Skip to main content
MAXCYTE, INC. logo

MAXCYTE, INC. — Investor Relations & Filings

Ticker · MXCT ISIN · US57777K1060 LEI · 54930053YHXULRFCU991 US Professional, scientific and technical activities
Open in API
Filings indexed 767 across all filing types
Latest filing 2021-02-23 Regulatory Filings
Country US United States of America
Listing US MXCT

About MAXCYTE, INC.

https://www.maxcyte.com/

MaxCyte, Inc. is a cell-engineering company that provides enabling platform technologies to advance the discovery, development, and commercialization of cell-based therapeutics. Its core offering is the ExPERT™ platform, which utilizes proprietary Flow Electroporation® technology for efficient, scalable, and non-viral transfection of complex cells. This technology supports a wide range of applications, including cell therapy, gene editing, antibody and protein production, and vaccine development. Additionally, MaxCyte offers SeQure™ genotoxicity assessment services to evaluate the safety of gene-edited products by detecting on- and off-target effects. The company employs a partnership-driven licensing model to support clients from early-stage research through to clinical and commercial manufacturing.

Recent filings

Filing Released Lang Actions
Participation in Upcoming Investor Conferences
Regulatory Filings Classification · 98% confidence The document is a press release announcing that MaxCyte, Inc. will participate in two upcoming virtual healthcare investor conferences. It provides details on the dates and the executives who will be presenting. It does not contain the actual presentation slides or financial reports, but rather serves as an announcement of future investor relations activities. As it does not fit into specific categories like 'Investor Presentation' (which would be the slides themselves) or 'Earnings Release', and is a general corporate announcement distributed via RNS Reach, it is best classified as a Regulatory Filing (RNS).
2021-02-23 English
Director Dealings and Issue of Equity
Director's Dealing Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement from MaxCyte, Inc. regarding a director's share transaction (Will Brooke exercising options and selling shares). It explicitly includes the required 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES' table. While it mentions total voting rights, the primary purpose is the disclosure of a director's dealing. Therefore, it is classified as a Director's Dealing (DIRS).
2021-02-19 English
Grant of Options
Director's Dealing Classification · 100% confidence The document is a formal notification of share option grants to Persons Discharging Managerial Responsibilities (PDMRs) at MaxCyte, Inc. It includes the standard regulatory disclosure table required under the Market Abuse Regulation (MAR) for transactions by directors and executives. This type of filing is specifically categorized as a Director's Dealing (DIRS) report, as it details personal share-related transactions by company leadership.
2021-02-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. This falls directly under the definition of a Major Shareholding Notification (MRQ).
2021-02-15 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings'. This is a regulatory requirement for shareholders to notify the issuer and the FCA when their voting rights cross certain thresholds. This fits the definition of a 'Major Shareholding Notification' (MRQ).
2021-02-12 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is a regulatory requirement for shareholders to disclose when their voting rights in a company cross certain thresholds. This is a classic 'Major Shareholding Notification' filing, which corresponds to the code 'MRQ'.
2021-02-08 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.